U.S. flag

An official website of the United States government

NM_000463.3(UGT1A1):c.578T>A (p.Val193Glu) AND not provided

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Dec 2, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001994959.4

Allele description [Variation Report for NM_000463.3(UGT1A1):c.578T>A (p.Val193Glu)]

NM_000463.3(UGT1A1):c.578T>A (p.Val193Glu)

Genes:
  • UGT1A:UDP glucuronosyltransferase family 1 member A complex locus [Gene - HGNC]
  • UGT1A10:UDP glucuronosyltransferase family 1 member A10 [Gene - OMIM - HGNC]
  • UGT1A1:UDP glucuronosyltransferase family 1 member A1 [Gene - OMIM - HGNC]
  • UGT1A3:UDP glucuronosyltransferase family 1 member A3 [Gene - OMIM - HGNC]
  • UGT1A4:UDP glucuronosyltransferase family 1 member A4 [Gene - OMIM - HGNC]
  • UGT1A5:UDP glucuronosyltransferase family 1 member A5 [Gene - OMIM - HGNC]
  • UGT1A6:UDP glucuronosyltransferase family 1 member A6 [Gene - OMIM - HGNC]
  • UGT1A7:UDP glucuronosyltransferase family 1 member A7 [Gene - OMIM - HGNC]
  • UGT1A8:UDP glucuronosyltransferase family 1 member A8 [Gene - OMIM - HGNC]
  • UGT1A9:UDP glucuronosyltransferase family 1 member A9 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2q37.1
Genomic location:
Preferred name:
NM_000463.3(UGT1A1):c.578T>A (p.Val193Glu)
HGVS:
  • NC_000002.12:g.233760865T>A
  • NG_002601.2:g.176122T>A
  • NG_033238.1:g.5593T>A
  • NM_000463.3:c.578T>AMANE SELECT
  • NM_001072.4:c.862-6169T>AMANE SELECT
  • NM_007120.3:c.868-6169T>AMANE SELECT
  • NM_019075.4:c.856-6169T>AMANE SELECT
  • NM_019076.5:c.856-6169T>AMANE SELECT
  • NM_019077.3:c.856-6169T>AMANE SELECT
  • NM_019078.2:c.868-6169T>AMANE SELECT
  • NM_019093.4:c.868-6169T>AMANE SELECT
  • NM_021027.3:c.856-6169T>AMANE SELECT
  • NM_205862.3:c.61-6169T>A
  • NP_000454.1:p.Val193Glu
  • NP_000454.1:p.Val193Glu
  • LRG_733t1:c.578T>A
  • LRG_733:g.5593T>A
  • LRG_733p1:p.Val193Glu
  • NC_000002.11:g.234669511T>A
  • NM_000463.2:c.578T>A
Protein change:
V193E
Links:
dbSNP: rs2125988381
NCBI 1000 Genomes Browser:
rs2125988381
Molecular consequence:
  • NM_001072.4:c.862-6169T>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_007120.3:c.868-6169T>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_019075.4:c.856-6169T>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_019076.5:c.856-6169T>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_019077.3:c.856-6169T>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_019078.2:c.868-6169T>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_019093.4:c.868-6169T>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_021027.3:c.856-6169T>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_205862.3:c.61-6169T>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000463.3:c.578T>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002243573Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Dec 2, 2021)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002243573.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Not Available"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Not Available"). This missense change has been observed in individual(s) with UGT1A1-related conditions (Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces valine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 193 of the UGT1A1 protein (p.Val193Glu).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024